Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LifeStance Health Grp Inc | David P. Bourdon | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 02 Sep 2026 | 150,000 | 1,248,247 | - | 0 | Common Stock | |
| Sonida Senior Living Inc | Michael Simanovsky | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 02 Sep 2026 | 100,373 | 0 (0%) | 0% | - | Common Stock | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 28.33 per share. | 02 Sep 2026 | 3,458 | 310,506 | - | 28.3 | 97,965 | Class A Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 02 Sep 2026 | 2,127 | 359,924 (1%) | 0% | 19.7 | 41,809 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 02 Sep 2026 | 1,673 | 986,117 (5%) | 0% | 19.7 | 32,885 | Common Stock |
| Teladoc Health Inc | Michael F. Grasher | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 239,616 | 239,616 | - | - | Restricted Stock Units | |
| Solventum | Bryan C. Hanson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 67,261 | 211,983 | - | - | Common Stock | |
| Solventum | Bryan C. Hanson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 67,261 | 0 | - | - | Restricted Stock Units | |
| Solventum | Bryan C. Hanson | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 90.95 per share. | 01 Sep 2026 | 26,468 | 185,515 | - | 91.0 | 2,407,265 | Common Stock |
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 01 Sep 2026 | 20,614 | 323,339 (2%) | 0% | 7.2 | 148,782 | Common Stock |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Sale of securities on an exchange or to another person at price $ 6.51 per share. | 01 Sep 2026 | 9,812 | 0 (0%) | 0% | 6.5 | 63,876 | Common Stock |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 9,152 | 54,918 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 9,152 | 124,763 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 9,152 | 54,918 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 9,152 | 98,889 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Carlos Nueno | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 8,717 | 52,302 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Carlos Nueno | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 8,717 | 70,944 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 8,717 | 15,251 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 8,717 | 52,302 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 01 Sep 2026 | 7,573 | 117,616 (0%) | 0% | 6.3 | 47,717 | Common Stock |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 01 Sep 2026 | 7,357 | 92,832 (0%) | 0% | 6.3 | 46,356 | Common Stock |
| Teladoc Health Inc | Carlos Nueno | President, International | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 01 Sep 2026 | 6,200 | 64,744 (0%) | 0% | 6.3 | 39,066 | Common Stock |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 5,492 | 5,492 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 5,492 | 5,492 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 01 Sep 2026 | 5,439 | 9,812 (0%) | 0% | 6.3 | 34,271 | Common Stock |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 5,350 | 115,611 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 5,350 | 10,700 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 4,859 | 9,718 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 4,859 | 89,737 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Carlos Nueno | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 4,556 | 62,227 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Carlos Nueno | President, International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 4,556 | 9,114 | - | - | Restricted Stock Units | |
| Fulgent Genetics Inc | Ming Hsieh | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.59 per share. | 01 Sep 2026 | 4,392 | 885,952 (4%) | 0% | 19.6 | 86,039 | Common Stock |
| Labcorp | Brian J. Caveney | EVP, Pres of BLS, CMO & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 3,000 | 7,170 | - | - | Restricted Stock Unit | |
| Neogenomics Inc | Alicia C. Olivo | EVP, GC & Business Development | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 01 Sep 2026 | 2,692 | 90,875 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Paul Kim | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.59 per share. | 01 Sep 2026 | 2,087 | 356,543 (1%) | 0% | 19.6 | 40,884 | Common Stock |
| Exagen Inc | Jeffrey G. Black | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 3.02 per share. | 01 Sep 2026 | 1,571 | 324,910 (2%) | 0% | 3.0 | 4,740 | Common Stock |
| Labcorp | Bryan T. Vaughn | EVP and President, Diagnostics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 1,500 | 5,204 | - | - | Restricted Stock Unit | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 1,300 | 7,798 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 1,300 | 100,189 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 1,042 | 6,534 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 1,042 | 2,084 | - | - | Restricted Stock Units | |
| Labcorp | Jonathan C. Meltzer | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 900 | 3,594 | - | - | Restricted Stock Unit | |
| Teladoc Health Inc | Joseph R. Catapano | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 833 | 13,100 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Joseph R. Catapano | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 833 | 5,001 | - | - | Restricted Stock Units | |
| Labcorp | Akinbolade Oyegunwa | EVP, CIO & CTO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2026 | 750 | 2,940 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 717 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 717 | 40,671 | - | 0 | Class A Common Stock | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 426 | 2,553 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 426 | 125,189 (0%) | 0% | - | Common Stock | |
| GeneDx Holdings Corp (Class A) | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 83.84 per share. | 01 Sep 2026 | 372 | 40,299 | - | 83.8 | 31,188 | Class A Common Stock |
| Teladoc Health Inc | Joseph R. Catapano | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.30 per share. | 01 Sep 2026 | 274 | 12,865 (0%) | 0% | 6.3 | 1,726 | Common Stock |
| Teladoc Health Inc | Joseph R. Catapano | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 39 | 232 | - | - | Performance Stock Units | |
| Teladoc Health Inc | Joseph R. Catapano | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2026 | 39 | 13,139 (0%) | 0% | - | Common Stock | |
| Sera Prognostics Inc (Class A) | Scott Gleason | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2026 | 169,624 | 169,624 | - | - | Stock Option (right to buy) | |
| Sera Prognostics Inc (Class A) | Scott Gleason | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2026 | 117,924 | 117,924 | - | 0 | Class A Common Stock | |
| Encompass Health Corp | Andrew L. Price | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 120.93 per share. | 31 Aug 2026 | 5,211 | 69,483 (0%) | 0% | 120.9 | 630,166 | Encompass Health Common Stock |
| Encompass Health Corp | John Patrick Darby | EVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Aug 2026 | 4,858 | 0 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Encompass Health Corp | John Patrick Darby | EVP, Gen Counsel & Secretary | Sale of securities on an exchange or to another person at price $ 121.09 per share. | 31 Aug 2026 | 4,858 | 75,041 (0%) | 0% | 121.1 | 588,255 | Encompass Health Common Stock |
| Encompass Health Corp | John Patrick Darby | EVP, Gen Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 35.06 per share. | 31 Aug 2026 | 4,858 | 79,899 (0%) | 0% | 35.1 | 170,321 | Encompass Health Common Stock |
| Sonida Senior Living Inc | Michael Simanovsky | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.42 per share. | 28 Aug 2026 | 97,581 | 100,373 (0%) | 0% | 38.4 | 3,749,062 | Common Stock |
| Sonida Senior Living Inc | Michael Simanovsky | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 38.16 per share. | 28 Aug 2026 | 21,792 | 202,569 (0%) | 0% | 38.2 | 831,583 | Common Stock |
| Sonida Senior Living Inc | Michael Simanovsky | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 28 Aug 2026 | 4,615 | 197,954 (0%) | 0% | 39.3 | 181,139 | Common Stock |
| Kindly MD Inc | Teresa S. Gendron | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2026 | 70,821 | 136,437 | - | 0 | Common Stock | |
| Kindly MD Inc | John Dalton | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2026 | 42,492 | 81,862 | - | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 27 Aug 2026 | 1,193 | 362,051 (1%) | 0% | 19.9 | 23,747 | Common Stock |
| Fulgent Genetics Inc | Hanlin Gao | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.91 per share. | 27 Aug 2026 | 939 | 987,790 (5%) | 0% | 19.9 | 18,691 | Common Stock |
| Fulgent Genetics Inc | Ming Hsieh | Director, Chief Executive Officer, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.81 per share. | 26 Aug 2026 | 2,949 | 890,344 (4%) | 0% | 19.8 | 58,420 | Common Stock |
| Fulgent Genetics Inc | Paul Kim | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.81 per share. | 26 Aug 2026 | 1,168 | 358,630 (1%) | 0% | 19.8 | 23,138 | Common Stock |
| GMR Solutions Inc Ordinary | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2026 | 976 | 976 | - | - | Restricted Stock Units | |
| GMR Solutions Inc Ordinary | Timothy A. Wicks | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2026 | 976 | 976 | - | - | Restricted Stock Units | |
| GMR Solutions Inc Ordinary | Jan Stern Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2026 | 976 | 976 | - | - | Restricted Stock Units | |
| GMR Solutions Inc Ordinary | Amar Desai | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2026 | 976 | 976 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.